|
Symbol
|
KYGDDU | KYFWDU | AAAHTQ | KYHHDU | KYDNDU | OLRRCH | KYIZDU | KYIJDU | OKXRCH | KYKCDU | RMA7YV | KYKTDU | KYKNDU | KYGYDU | KYLSDU | KYNDDU | RMBBDV | AANUTQ | OQTRCH | KYNWDU |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nom | Autocallable Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Autocallable Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Worst of Reverse Convertible | Callable Multi Barrier Reverse Convertible | Autocallable Multi Barrier Reverse Convertible | Worst of Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Autocallable Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Autocallable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Barrier Reverse Convertible | Worst of Reverse Convertible | Multi Barrier Reverse Convertible |
|
Sous-jacent
|
Partners Group Hldg. AG / Swiss RE AG / UBS Group AG | Partners Group Hldg. AG / UBS Group AG / Zurich Insurance Group AG | Alcon / Partners Group Hldg. AG / UBS Group AG | Partners Group Hldg. AG / UBS Group AG | Partners Group Hldg. AG / Swiss RE AG / UBS Group AG | Givaudan / Partners Group Hldg. AG / Sika AG | ABB / Partners Group Hldg. AG / Roche PS | Julius Baer Group / Partners Group Hldg. AG / Swiss RE AG | ABB N / Givaudan / Partners Group Hldg. AG | Givaudan / Nestlé N / Partners Group Hldg. AG | Nestlé S.A. / Novartis AG / Partners Group Hldg. AG / Roche PS / UBS Group AG | Adecco Group AG / Kühne & Nagel Intl. AG / Partners Group Hldg. AG | Partners Group Hldg. AG / Swiss Life Hldg. N / Swiss RE AG | Partners Group Hldg. AG / Swiss RE AG / Zurich Insurance Group AG | ABB / Partners Group Hldg. AG / Roche PS | Julius Baer Group / Partners Group Hldg. AG / Swiss Life Hldg. N / Swiss RE AG | Julius Baer Group / Nestlé S.A. / Novartis AG / Partners Group Hldg. AG / Roche PS | Julius Baer Group / Nestlé S.A. / Novartis AG / Partners Group Hldg. AG / Roche PS | Givaudan / Partners Group Hldg. AG / Sika AG / UBS Group AG | Compagnie Financière Richemont SA / Partners Group Hldg. AG / Sika AG |
|
Emetteur
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Échéance
|
29.06.2026 | 29.06.2026 | 24.06.2026 | 03.07.2026 | 12.06.2026 | 01.07.2026 | 10.07.2026 | 10.07.2026 | 24.06.2026 | 17.07.2026 | 05.01.2027 | 24.07.2026 | 24.07.2026 | 03.07.2026 | 31.07.2026 | 10.08.2026 | 18.01.2027 | 05.08.2026 | 05.08.2026 | 14.08.2026 |
| Demande | 94,80 | 60,05 | 98,42 | 95,70 | - | 60,32 | 59,95 | 60,10 | 100,97 | 58,30 | 83,60 | 52,25 | 73,60 | 62,00 | 59,15 | 91,45 | - | 78,58 | 57,67 | 60,20 |
| Offre | 95,80 | 61,05 | - | 96,70 | - | - | 60,95 | 61,10 | - | 59,30 | - | 53,25 | 74,60 | 63,00 | 60,15 | 92,45 | - | - | - | 61,20 |